TNF and rheumatoid arthritis: The main finding of the present study is that in RA and AS patients, a decline in classical (CD14hiCD16−) monocytes was observed during anti-TNF-α treatment in comparison to placebo, while the amount of CD14dimCD16+ monocytes increased.